Filing Details

Accession Number:
0001209191-16-146639
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-10-21 18:17:10
Reporting Period:
2016-10-19
Filing Date:
2016-10-21
Accepted Time:
2016-10-21 18:17:10
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1044378 Biocept Inc BIOC Services-Medical Laboratories (8071) 330757995
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1679894 Timothy Kennedy 5810 Nancy Ridge Drive, Suite 150
San Diego CA 92121
Cfo, Sr V.p. Operations & Sec. No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-10-19 36,363 $1.10 61,363 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Warrant to Purchase Common Stock Acquisiton 2016-10-19 36,363 $0.00 36,363 $1.10
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
36,363 2016-10-19 2021-10-19 No 4 P Direct
Footnotes
  1. Shares were purchased from the issuer in a unit offering, with each unit consisting of one share of Common Stock and one warrant to purchase one share of Common Stock for $1.10 per unit.
  2. On September 27, 2016, the Issuer effected a 1-for-3 reverse stock split resulting in the reporting person's ownership of 50,000 fewer shares.